InvestorsHub Logo
Followers 21
Posts 1596
Boards Moderated 1
Alias Born 09/16/2008

Re: Enterprising Investor post# 61

Friday, 03/06/2015 11:19:27 AM

Friday, March 06, 2015 11:19:27 AM

Post# of 85
The FDA will likely require further action from the company on at least one or more issues in the form 483 response, resulting in further delay of Augment approval. Odds are WMGIZ will head lower, all imo.

Bob Palmisano - President and CEO

"The inspection that occurred at the vendor had 13 observations."

Source: http://seekingalpha.com/article/2951646-wright-medical-groups-wmgi-ceo-robert-palmisano-on-q4-2014-results-earnings-call-transcript?part=single